AKT1 and colorectal carcinoma: The molecular marker of hypoxia is hypoxia-inducible factor 1α (HIF-1α) [20], which was already connected with CRC resistance to therapy with 5-fluorouracil in phosphoinositide 3-kinase (PI3K)/protein B kinase (Akt) and β-catenin-dependent manner.